It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Chronic HIV infection causes persistent low-grade inflammation that induces premature aging of the immune system including senescence of memory and effector CD8 T cells. To uncover the reasons of gradually diminished potency of CD8 T cells from people living with HIV, here we expose the T cells to planar lipid bilayers containing ligands for T-cell receptor and a T-cell integrins and analyze the cellular morphology, dynamics of synaptic interface formation and patterns of the cellular degranulation. We find a large fraction of phenotypically naive T cells from chronically infected people are capable to form mature synapse with focused degranulation, a signature of a differentiated T cells. Further, differentiation of aberrant naive T cells may lead to the development of anomalous effector T cells undermining their capacity to control HIV and other pathogens that could be contained otherwise.
HIV infection over time is thought to result in premature aging and aberrant immune responses including the induction of immunological senescence. Here the authors show altered formation of immune synapses by naive CD8+ T cells and dysregulated synapse functioning at late differentiated stages in people living with HIV.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Thomas Jefferson University, Department of Microbiology and Immunology, Philadelphia, USA (GRID:grid.265008.9) (ISNI:0000 0001 2166 5843)
2 Perelman School of Medicine, University of Pennsylvania, Department of Microbiology and Institute of Immunology, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
3 Perelman School of Medicine, University of Pennsylvania, Department of Microbiology and Institute of Immunology, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972); Karolinska Institutet, Karolinska University Hospital Huddinge, Department of Medicine Huddinge, Stockholm, Sweden (GRID:grid.24381.3c) (ISNI:0000 0000 9241 5705)
4 Thomas Jefferson University, Departments of Immunology and Medical Oncology, Philadelphia, USA (GRID:grid.265008.9) (ISNI:0000 0001 2166 5843); Thomas Jefferson University, Sydney Kimmel Cancer Center, Philadelphia, USA (GRID:grid.265008.9) (ISNI:0000 0001 2166 5843)